FDA Issues Safety Warning for Heart Rhythm Drug Multaq
According to a report from the Injury Board, the heart rhythm drug, Multaq, has been issued a safety warning by the U.S. Food and Drug Administration (FDA). Multaq (dronedarone) was approved in 2009 for the treatment of atrial fibrillation and atrial flutter. Both of these…